No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
THC240719C135000
- 1.52
- +0.07+4.83%
15min DelayClose Jul 16 16:00 ET
1.52High1.52Low
1.52Open1.45Pre Close1 Volume473 Open Interest135.00Strike Price152.00Turnover45.49%IV2.35%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry1.52Extrinsic Value100Contract SizeAmericanOptions Type0.3920Delta0.0730Gamma93.61Leverage Ratio-0.4117Theta0.0038Rho36.69Eff Leverage0.0445Vega
Intraday
- 5D
- Daily
News
Tenet Healthcare Is Maintained at Buy by Truist Securities
Tenet Healthcare Is Maintained at Buy by Truist
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $155
Truist Financial analyst David S Macdonald maintains $Tenet Healthcare(THC.US)$ with a buy rating, and adjusts the target price from $130 to $155.According to TipRanks data, the analyst has a
Express News | Tenet Healthcare Corp : Truist Securities Raises Target Price to $155 From $130
Here's Why Tenet Healthcare (THC) Gained But Lagged the Market Today
Peering Into Tenet Healthcare's Recent Short Interest
Tenet Healthcare's (NYSE:THC) short percent of float has fallen 8.9% since its last report. The company recently reported that it has 4.60 million shares sold short, which is 6.14% of all regular
Express News | Tenet Healthcare Corp : Mizuho Raises Target Price to $145 From $130
Comments
$Scynexis(SCYX.US$
$Nanoviricides(NNVC.US$
$Tenet Healthcare(THC.US$
I want to watch these the most, I think, and now to find stuff in a different sector..
$Nanoviricides(NNVC.US$
$Tenet Healthcare(THC.US$
I want to watch these the most, I think, and now to find stuff in a different sector..
1
The landscape of U.S. equities is abuzz with anticipation as artificial intelligence (AI) cements its place as a transformative force in the technology sector. In a recent analysis by $Goldman Sachs(GS.US$, optimism for AI integration remains robust, yet valuations steer clear of the vertiginous heights of previous market bubbles.
Goldman Sachs' insights reveal that market-implied long-term growth expectations hav...
Goldman Sachs' insights reveal that market-implied long-term growth expectations hav...
78
1
The significant stock sale by an insider at a lower price is seen as a negative signal. However, high insider ownership in Tenet Healthcare may indicate the company's interest in all shareholders. The absence of insider buying over the past year, despite profitability and growth, could be worrying.
Insider selling of Tenet Healthcare's stock below current price is discouraging, suggesting satisfaction with lower valuation. High insider ownership is positive, indicating alignment with shareholders. Yet, lack of recent insider buying and selling activity prompts caution.
Tenet Healthcare's respectable ROE is overshadowed by its high debt level, increasing risk and limiting future options. A high ROE without debt signifies a high-quality business. Between two companies with equal ROE, the less indebted one is preferred.
Read more